Posts by: Patricia Inacio, PhD

News

A Phase 1 clinical trial assessing Amgen’s immunotherapy AMG 330 showed promising results in acute myeloid leukemia (AML) patients who received at least one prior treatment, the company announced. AMG 330, given at 120 and 240 ... Read more

December 11, 2018

FDA Approves Tecentriq Combo as Initial Treatment for Select Patients with Advanced NSCLC

News

The U.S. Food and Drug Administration (FDA) has approved Tecentriq (atezolizumab), in combination with Avastin (bevacizumab) and the chemotherapies Taxol (paclitaxel) and carboplatin, for a first-line treatment of certain patients with metastatic non-squamous ... Read more

December 4, 2018

Yervoy, Local Injection of Candidate Therapy Tilsotolimod Shrink Advanced Melanoma Tumors, Trial Shows

News

A combination of Yervoy (ipilimumab) and Idera Pharmaceuticals’ investigational tilsotolimod reduced tumors in four out of 10 advanced melanoma patients included in a Phase 1/2 trial. Findings from the ILLUMINATE-204 trial (NCT02644967) were presented at the European ... Read more

September 5, 2018

New UNC Software Aims to Make Stem Cell Transplants Safer for Leukemia Patients

News

New computer software is able to identify targets for potential immunotherapies in individual leukemia patients undergoing stem cell transplants, a new study shows. These results open the door for tailored ... Read more

August 21, 2018September 20, 2018

FDA Approves Opdivo for Certain Patients with Advanced Small Cell Lung Cancer

News

The U.S. Food and Drug Administration has approved Opdivo (nivolumab) to treat patients with metastatic small cell lung cancer (SCLC) who failed to respond to platinum-based chemotherapy and at least one ... Read more

July 20, 2018July 20, 2018

Immunotherapy Use Can Double Survival Rate of Melanoma Patients with Brain Metastasis, Large Study Reports

News

Melanoma patients with brain metastasis have seen significant improvements in their survival rates since immune checkpoint inhibitors like Yervoy (ipilimumab) came into treatment use, a study based on “real-life” ... Read more

July 10, 2018July 10, 2018

Study Will Test CAR T-cell Immunotherapy in Young People with Brain, Spinal Cord Tumors

News

The Seattle Children’s Hospital is conducting a pioneering clinical trial testing engineered immune cells as a treatment for children and young adults with a kind of brain cancer that produces ... Read more

June 8, 2018

Immunotherapy Targeting Tumor Mutations Leads to Complete Response in Advanced Breast Cancer Patient, NIH Reports

News

A tweaked version of a cellular immunotherapy that recognizes mutations in a patient’s tumor has led to the complete regression of metastatic breast cancer in a woman whose disease ... Read more

May 4, 2018

Advanced Melanoma Patients Seen to Respond to CMP-001, Keytruda Combo in Ongoing Study

News

Intratumoral injection of CMP-001 in combination with Keytruda (pembrolizumab) worked to reduce tumor burden in advanced melanoma patients whose disease failed to respond, or progressed, when treated with PD-1 inhibitors, ... Read more

April 24, 2018April 24, 2018

CAR T-cell Therapy at Higher Dose Might Treat Advanced Neuroblastoma, Early Trial Results Suggest

News

At higher doses, an immunotherapy approach using chimeric antigen receptor (CAR) T-cells may help to treat advanced neuroblastoma, a rare cancer that mostly affects babies and young children, according to ... Read more

Posts by: Patricia Inacio, PhD

Patricia Inacio, PhD

AMG 330 Immunotherapy Shows Promise in Relapsed or Refractory Acute Myeloid Leukemia

FDA Approves Tecentriq Combo as Initial Treatment for Select Patients with Advanced NSCLC

Yervoy, Local Injection of Candidate Therapy Tilsotolimod Shrink Advanced Melanoma Tumors, Trial Shows

New UNC Software Aims to Make Stem Cell Transplants Safer for Leukemia Patients

FDA Approves Opdivo for Certain Patients with Advanced Small Cell Lung Cancer

Immunotherapy Use Can Double Survival Rate of Melanoma Patients with Brain Metastasis, Large Study Reports

Study Will Test CAR T-cell Immunotherapy in Young People with Brain, Spinal Cord Tumors

Immunotherapy Targeting Tumor Mutations Leads to Complete Response in Advanced Breast Cancer Patient, NIH Reports

Advanced Melanoma Patients Seen to Respond to CMP-001, Keytruda Combo in Ongoing Study

CAR T-cell Therapy at Higher Dose Might Treat Advanced Neuroblastoma, Early Trial Results Suggest

Pin It on Pinterest